N PY IS THE strongest physiological stimulant of feeding yet described (1-3). For its powerful orexigenic effect, especially on carbohydrate intake, NPY is considered the naturally occurring appetite transducer in vertebrate species. When injected centrally, NPY induces a robust feeding response (4, 5), and chronic infusion results in hyperfagia and obesity in rats (6 -10). In addition, passive immunoneutralization of NPY in normal and VMH-lesioned rats significantly reduces food intake (11, 12), suggesting a physiological role of NPY in the induction of feeding behavior in normal and hyperfagic rats. NPY is synthesized in neurons of the hypothalamic arcuate nucleus (ARC) that projects in adjacent areas, such as paraventricular (PVN), dorsomedial (DMH), and ventromedial (VMH) hypothalamic nuclei, that are involved in the control of food intake (13, 14) . NPY synthesis in the ARC and its release in PVN and DMH are all up-regulated in several experimental paradigms with increased energy and metabolic demand, such as starvation, diabetes, and lactation (2, 3). Despite the consistent evidence that NPY plays a central role in stimulating appetite, NPY deficiency, due to targeted genetic deletion, fails to affect ingestive behavior and body weight in normally fed or fasted mice (15, 16). Current morphological and experimental evidence suggest that an interconnected network of NPY, additional orexigenic peptides (galanin and opioids), and neurotransmitters (GABA and norepinephrine) integrates the hypothalamic regulation of daily food intake (2, 3). The observation that NPY-knockout mice are phenotypically normal suggests that this biological redundancy of multiple appetite-stimulating pathway might play a crucial role in the daily management of energy homeostasis when NPY signaling is impaired (2, 3) .
N PY IS THE strongest physiological stimulant of feeding yet described (1) (2) (3) . For its powerful orexigenic effect, especially on carbohydrate intake, NPY is considered the naturally occurring appetite transducer in vertebrate species. When injected centrally, NPY induces a robust feeding response (4, 5) , and chronic infusion results in hyperfagia and obesity in rats (6 -10) . In addition, passive immunoneutralization of NPY in normal and VMH-lesioned rats significantly reduces food intake (11, 12) , suggesting a physiological role of NPY in the induction of feeding behavior in normal and hyperfagic rats. NPY is synthesized in neurons of the hypothalamic arcuate nucleus (ARC) that projects in adjacent areas, such as paraventricular (PVN), dorsomedial (DMH), and ventromedial (VMH) hypothalamic nuclei, that are involved in the control of food intake (13, 14) . NPY synthesis in the ARC and its release in PVN and DMH are all up-regulated in several experimental paradigms with increased energy and metabolic demand, such as starvation, diabetes, and lactation (2, 3) . Despite the consistent evidence that NPY plays a central role in stimulating appetite, NPY deficiency, due to targeted genetic deletion, fails to affect ingestive behavior and body weight in normally fed or fasted mice (15, 16) . Current morphological and experimental evidence suggest that an interconnected network of NPY, additional orexigenic peptides (galanin and opioids), and neurotransmitters (GABA and norepinephrine) integrates the hypothalamic regulation of daily food intake (2, 3). The observation that NPY-knockout mice are phenotypically normal suggests that this biological redundancy of multiple appetite-stimulating pathway might play a crucial role in the daily management of energy homeostasis when NPY signaling is impaired (2, 3) .
Leptin, an adipocyte-derived hormone, inhibits food intake and may play a key role in regulating the daily pattern of food intake and energy homeostasis (17) (18) (19) . An increase in body fat increases levels of leptin that, in turn, reduces food intake, whereas a decrease in body fat leads to a decreased level of the circulating hormone and to a stimulation of food intake (20) . Mutations that result in leptin deficiency, or in leptin resistance, are associated with massive obesity in humans and rodents (21, 22) .
Although NPY is not the only downstream regulator of body adiposity that responds to leptin, several lines of evidence indicate that NPY is a key component of leptin targets (3) . NPY neurons within the ARC coexpress leptin receptor mRNA (23) (24) (25) (26) . Leptin administration suppresses, in vitro and in vivo, NPY gene expression in the ARC and its release into the PVN, the most abundant projection region (20, 26, 27) . In addition, leptin deficiency in the fasting state or in the ob/ob mice and leptin resistance in the db/db mice markedly elevates arcuate NPY mRNA, whereas leptin administration decreases NPY mRNA in ob/ob mice and fasted rats (20, 26, 27) . Therefore, diminution of leptin feedback or leptin resis-tance may contribute to the hyperfagia and obesity through the modifications of the NPY orexigenic network.
The physiological actions of NPY in the central nervous system are mediated via, at least, six different receptor subtypes: Y 1 -Y 6 (28) . Both Y 1 and Y 5 receptors are expressed in the ARC, PVN, DMH, and VMH (29 -32) . The Y 5 receptor has been isolated as the receptor that has pharmacological properties most closely matching a proposed feeding receptor (33) (34) (35) (36) (37) . However, the potent anorectic effect of selective Y 1 receptor antagonists suggests that Y 1 receptor is also involved in appetite regulation (38 -41) . Recent studies, obtained from mutant mice lacking the Y 1 or the Y 5 receptor, demonstrated that, although both of the mutant mice feed and grow normally, the Y 1 receptor knockout mice exhibit a marked reduced feeding response to fasting, whereas the feeding response of Y 5 receptor knockout mice to NPY is significantly reduced, suggesting that both of the receptors are required for appetite regulation by NPY (35, 42, 43 The sections were counterstained with neutral fast red, and hypothalamic nuclei were identified on the basis of the mouse brain atlas (46) . Sections were digitized by using a built-in green filter to better identify the nuclei extension and reduce the histochemical signal.
Materials and Methods

Experimental animals
Adult male (25-30 g ) Y 1 R/LacZ transgenic mice from transgenic line 62 were obtained from our breeding colony (44) . The animals were kept under a 12-h light, 12-h dark cycle, at 21Ϯ 2 C, and experiments were performed at the same time on each day to avoid any circadian effects. Animal care and handling throughout the experimental procedure were in strict accordance with the European Community Council Directive, 24 November 1986 (86/609/EEC), and the protocol was approved by the Animal Investigation Committee of the Ministero dell'Università e della Ricerca Scientifica e Tecnologica.
Treatments
To test the effect of food deprivation on Y 1 R/LacZ mice, animals were randomly divided into two groups of mice that were food deprived for 48 (FD48) and 72 (FD72) h, respectively. Water was available ad libitum to all mice.
To test the effect of leptin treatment to control or fasted mice, animals were divided into two groups: one group of mice had free access to food and water and received a single daily ip injection of 1 g/g of murine recombinant leptin (LEP) (Sigma-Aldrich Corp., Milano, Italy). The other group was fasted for 72 h and treated for 3 d with leptin (1 g/g, ip) (FD72 ϩ LEP).
To study the effect of glucose administration on Y 1 R/LacZ expression, mice were divided into four groups: one group of mice was allowed to feed freely and received 10% glucose in the drinking water for 72 h (GLU). Two groups of mice were fasted for 48 or 72 h and received 10% glucose in the drinking water (FD48 ϩ GLU, FD72 ϩ GLU, respectively). One group of mice was fasted for 72 h, received a 10% glucose in the drinking water and was treated daily with leptin (1 g/g, ip) (FD72 ϩ GLU ϩ LEP).
Finally, one group of mice with free access to food and water received a single daily ip injection of saline and served as a control group (VEH).
Mice were fed standard lab chow (Harlan Italy, S. Pietro al Natisone, Udine, Italy) providing 41.2% energy as amid, 4.9 as sugar, 18.9 as protein, and 5.7 as fat. The addition of 10% glucose to the drinking water did not induce a significant change in daily energy intake, because food consumption of mice receiving a 10% GLU was 66% lower than control mice. However, there was a significant difference in dietary composition, because supplementing of the drinking water with 10% glucose supplied approximately 53% energy as sugar.
All mice were weighted daily for 3 d, at 1600 h and were killed by cervical dislocation at the end of the d 2 or at the end of d 3 (for 48 hor 72 h-fasted mice respectively).
Brains were quickly removed, placed in 10% embedding medium (Bio-optica, Milano, Italy) in PBS, frozen on crushed dry ice, and stored at Ϫ80 C until assayed.
␤-galactosidase staining Y 1 R/LacZ expression was determined by ␤-galactosidase staining of brain coronal sections, as previously described (44, 45) . Briefly, frozen brains were cut on a cryostat at Ϫ20 C. Twenty-five-m-thick sections were collected on clean slides starting from a level corresponding to the end of the anterior commissure. Sections were dehydrated with acetonechloroform (1:1), air dried and shortly fixed in 2.5% glutaraldehyde in PBS (each step for 5 min on ice), and incubated overnight at 37 C in a solution containing 1 mg/ml of X-gal, 5 mm potassium ferrocyanide, 5 mm potassium ferrocyanide, 2 mm MgCl 2 , 0.01% Triton X-100 in PBS. After washing in water, sections were counterstained with nuclear fast red, dried and coverslipped with DPX mounting medium (Fluka Chemical Co., Buchs, Switzerland).
Quantitation of transgene expression as determined by ␤-galactosidase histochemistry
Quantitation of the Y 1 R/LacZ transgene expression was made by computer assisted morphometrical analysis as previously described (45) . To facilitate the neuroanatomical identification of the regions, the sections were counterstained with neutral fast red, and hypothalamic nuclei were identified on the basis of the mouse brain atlas of Franklin and Paxinos (46) . The expression of the transgene appears as mediumsized blue dots.
The ARC, DMH, and VMH nuclei were divided into a rostral, mid and caudal levels (around bregma Ϫ1.34, Ϫ1.70, Ϫ2.06 mm for the ARC; around bregma Ϫ1.46, Ϫ1.70, Ϫ2.06 mm for the DMH; around bregma Ϫ1.22, Ϫ1.70, Ϫ2.06 mm for VMH). For each of these three levels, two sections per animal were analyzed. Two standardized sections of comparable levels of the PVN (around bregma Ϫ0.70/-0.82 mm) and of the medial amygdaloid nucleus (AMY) (around bregma Ϫ1.70 mm) were examined for each animal. Selected sections were placed on a Carl Zeiss Axioplan I microscope, observed by means of a ϫ10 objective, and the corresponding image was transferred, via a black and white CCD camera (PCO, VC44, Keilheim, Germany), to a digitizing board (Scion LG-3, Scion Co, Frederick, MD) placed in a PowerPC 8200 Macintosh computer. Acquisition and analysis of the images were performed using the software NIH-Image (version 1.62, a freeware by W. Rasband, NIH, Bethesda, MD). Sections were observed and digitized first by using a built-in green filter to better identify the nuclei extension (Fig. 1) . A line, drawn following the boundaries of the selected nuclei, defined the area of interest (AOI, Figs. 3 and 4 ). The same section was then digitized using a built-in red filter obtaining a strong enhancement of the histochemical signal, but losing the definition of the nuclear boundaries. The AOI selected on the first image was finally superimposed on the second image to delimit the region in which dots should be counted. Using a manual thresholding method, dots were selected and the corresponding image was binarized. For each animal and nucleus, the cumulative number of dots and the cumulative areas of the analyzed sections were considered to obtain the density expression of the transgene expressed as dots per m 2 . The ARC, DMH, and VMH hypothalamic nuclei exhibited low to moderate histochemical staining, whereas a the highest level of expression was observed in the PVN, as previously described (44) .
Data analysis
Data are expressed as means Ϯ sem. They were statistically examined using one-way ANOVA and the appropriate contrasts analyzed by the Newman-Keuls test for multiple comparisons. 
Results
Effect of fasting, leptin treatment, and glucose administration on Y 1 R/LacZ mice body weight
Food deprivation for 24, 48, and 72 h significantly decreased mice body weight by 18%, 26%, and 28%, respectively, compared with their starting body weight at d 0 (Fig. 2) .
Leptin treatment did not reduce body weight of normally fed or of fasted mice. Conversely, supplementing the drinking water with 10% glucose, which did not change body weight of normally fed mice, completely prevents the decrease in body weight induced by 24, 48 and 72 h fasting (Fig. 2) . 
Effect of fasting, leptin treatment, and supplementing of drinking water with 10% glucose on Y 1 R/LacZ transgene expression in the PVN
Y 1 R/LacZ transgene expression was determined by histochemical ␤-galactosidase staining of brain coronal sections of the PVN using the chromogenic substrate X-gal. Fasting for 72 h decreased ␤-galactosidase staining in PVN compared with normally fed mice (Fig. 3, A and C) , and leptin treatment (1 g/g for 3 d) abrogates this effect (Fig. 3D) . Conversely, an increased ␤-galactosidase staining was observed in the PVN of normally fed mice with free access to a 10% glucose solution (Fig. 3B) . Quantitative analysis (summarized in Fig.  5 ) demonstrated that 72 h fasting decreased ␤-galactosidase expression in the PVN by 50% compared with normally fed mice (Fig. 5A) . Leptin treatment of fasted animals abrogates this effect but failed to modify Y 1 R/LacZ expression in normally fed mice. Conversely, supplementing the drinking water with 10% glucose significantly increased ␤-galactosidase expression in fed mice and prevented the decrease of transgene expression induced by food deprivation for 72 h (Fig.  5A) . No significant changes in ␤-galactosidase expression were observed in the PVN of mice food-deprived for 48 h with free access to normal drinking water or to drinking water supplemented with 10% glucose, compared with normally fed mice (Fig. 5B) .
Effect of fasting, glucose and leptin administration on Y 1 R/LacZ transgene expression in the ARC
Different results were observed at the level of ARC. Figure  4 shows that ␤-galactosidase staining in the rostral level of the ARC of 72 h fasted mice (Fig. 4C) and of 72 h-fasted mice treated for 3 d with 1 g/g of murine recombinant leptin (Fig.  4D) was not different from staining in the corresponding level of the ARC of normally fed mice (Fig. 4A) . Conversely, supplementing the drinking water with 10% glucose increased ␤-galactosidase staining in the rostral level of the ARC of normally fed mice (Fig. 4B) . Quantitative analysis (illustrated in Fig. 6 ) demonstrated that fasting and leptin treatment did not affect significantly Y 1 R/LacZ transgene expression in the rostral, mid and caudal levels of the ARC (Fig. 6A) . Glucose administration significantly increased transgene expression in the rostral and mid levels of the ARC of normally fed mice (by 78 and 36%, respectively) but failed to affect transgene expression in the caudal level of the ARC (Fig. 6A) . Furthermore, supplementing the drinking water with 10% glucose increased ␤-galactosidase expression in the rostral and mid levels of the ARC of mice fasted for 48 h by 46% and 40%, respectively (Fig. 6B) . Leptin treatment or glucose administration did not affect transgene expression in the rostral, mid, or caudal levels of the ARC of mice fasted for 72 h (Fig. 6A) .
Lack of effects of experimental treatments on Y 1 R/LacZ transgene expression in other hypothalamic and nonhypothalamic nuclei
Quantitative analysis of rostral, mid, and caudal levels of two other hypothalamic nuclei involved in the regulation of feeding, such as the VMH and DMH, demonstrated that fasting, leptin treatment or supplementing the drinking water with 10% glucose did not induced significant changes on ␤-galactosidase expression (Fig. 7) . Leptin treatment and glucose administration also failed to affect ␤-galactosidase expression in the VHM and DMH of 72-h fasted mice (data not shown).
Similarly, none of the treatments affected transgene expression in the AMY, chosen as a control region (data not shown).
Discussion
In rodents, compensatory changes in Y 1 receptor gene expression may reflect parallel changes in the functional activity of NPY-Y 1 receptor-mediated neurotransmission (2, 47) . In this study, we examined the effect of food deprivation, glucose administration, and leptin treatment on hypothalamic Y 1 receptor gene, using Y 1 R/LacZ transgene expression as a marker of altered signal transduction. Our results demonstrate that changes in feeding behavior induce a marked plasticity in the expression of the Y 1 R/LacZ transgene in specific regions of the hypothalamus but not in extrahypothalamic sites, such as the medial amygdala, providing further support for a functional role of the Y 1 receptor subtype in the circuit that regulates food intake.
A goal of our studies was to identify the hypothalamic nuclei where changes in Y 1 receptor gene expression correlate with altered feeding behavior and leptin treatment. In this regard, we demonstrated that fasting, leptin treatment, and glucose administration differentially affect Y 1 R/LacZ in the hypothalamic sites involved in the daily regulation of ingesting behavior and energy balance (ARC, PVN, DMH, and VMH). In particular, fasting decreased transgene expression in PVN but not in ARC, leptin treatment counteracted the fasting-induced decrease in transgene expression in the PVN, and supplementing the drinking water with glucose increased transgene expression in both the PVN and the ARC. Finally, none of the treatments altered transgene expression in DMH, VMH, and AMY.
Fasting for 72 h induces a marked decrease in the transgene expression only in the PVN. Leptin, completely ineffective on its own, abolishes this effect. This observation suggests that Y 1 receptor in PVN participate in the regulation of energy homeostasis and that the target cells mediating the restrain by leptin on NPY-induced feeding response (26 -27, 48) resides in this nucleus. We could speculate that, in a state of negative energetic balance, when the orexigenic NPYergic pathway projecting from ARC to PVN is activated and the NPY release in the PVN increased (49, 50) , Y 1 receptor is down-regulated in the PVN. Leptin, which blunts the effect of fasting to increase NPY mRNA (27) , prevents the food deprivation-induced reduction of Y 1 receptor gene expression. These results are in line with previous studies showing that a subset of Y 1 receptor-containing neurons in PVN may be the site of interplay between leptin and NPY in regulation of feeding and that this interplay is apparent during fasting (48, 51) .
Earlier reports showed that 48 h fasting reduces the number of Y 1 -receptor immunoreactive cells and Y 1 receptor mRNA levels in the ARC (52) . It is possible that the fastinginduced activation of the ARC NPY system may change the steady-state of ARC Y 1 receptor by other mechanisms, such as alteration in the mRNA stability or degradation. Alternatively, the time course of shifts of Y 1 receptor transcription and translation might be different.
Another interesting finding of this study, which is consistent with other reports (53) and requires comments, is that leptin reverses the fasting-induced decrease in Y 1 R/LacZ expression in PVN but fails to decrease mice body weight. These results show that the inhibition of arcuate NPY neurons and the weight reduction are triggered by leptin at different sensitivities and that these two events can become dissociated. These data also provide further evidence that NPY is not the only downstream regulator of adiposity that responds to leptin.
Conversely, supplementing the drinking water with 10% glucose increases Y 1 R/LacZ transgene expression both in ARC and PVN of normally fed mice, suggesting that a change in the diet composition, with an increase in sugar intake, elicits the up-regulation of Y 1 receptors in these nuclei. Furthermore, glucose administration to 48 h-fasted mice increases in Y 1 R/LacZ expression in the rostral and mid levels of the ARC but not in the PVN, suggesting that the arcuate NPY-Y 1 system is more sensitive to positive changes in energy balance.
Collectively, these observations suggest a different functional role for the Y 1 receptor in the ARC. Within the ARC, local circuit NPY neurons innervate a group of POMC neurons, projecting to the PVN and DMH, that also express Y 1 receptor mRNA (54, 55) . Recent studies indicate that arcuate NPY and POMC population antagonistically interact and that NPY inhibits the anorexigenic ARC/DMH pathway by activating the inhibitory Y 1 receptor located on the POMC cell body (54 -56) . We can speculate that, in a state of positive energetic balance, when POMC product and others anorectic signals must be activated, the NPY inhibitory signal to POMC is also inhibited, triggering the up-regulation of Y 1 receptor in ARC. This hypothesis is supported by the observation that glucose administration increases Y 1 R/LacZ transgene expression in the rostral and mid levels of the ARC, where the percentage of Y 1 receptor-like immunoreactive neurons that coexpress ACTH/POMC immunoreactivity is highest, but it fails to affect transgene expression in more caudal regions where number of Y 1 receptor/ACTH positive neurons decreases significantly (54) .
On the other hand, the effect of glucose on Y 1 receptor gene expression draws in another negative feedback signal beside leptin that regulates the synthesis and release of effector molecules such as NPY. This might correspond to insulin, which is secreted in response to meals (57) . The possibility that insulin may play a role in the glucose-induced development of ARC Y 1 receptor up-regulation is currently under investigation.
Finally, in the present study we demonstrated that the expression of Y 1 R-LacZ in the DMH and VMH was not altered to significant extent by any of the treatments. It is possible that, in VMH and DMH, starvation or leptin and glucose administration might induce changes in the expression of other NPY receptor subtypes, such as the Y 5 receptor. Alternatively, other factors, such as glucocorticoids, might be required to modulate the NPY-Y 1 signaling within the VMH. In line with this possibility, Wisialowsky and co-workers (58) recently reported that adrenalectomy induces the downregulation of Y 1 receptor mRNA selectively in the VMH but not in the ARC or in the PVN.
In conclusion, our data suggest that the decrease in the energetic balance, induced by fasting, down-regulates Y 1 receptor gene expression only in PVN and that leptin treatment abrogates this effect. Conversely, an increase in sugar intake, induced by glucose administration, up-regulates Y 1 receptor gene expression both in PVN and ARC. These results are consistent with the hypothesis that the ARC and PVN Y 1 receptor participate in the regulation of feeding behavior and that the NPY-Y 1 system projecting to PVN is under the control of leptin.
